Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Research Protocols

Date Submitted: Nov 11, 2023
Date Accepted: Apr 25, 2024

The final, peer-reviewed published version of this preprint can be found here:

Standard Versus Family-Based Screening, Brief Intervention, and Referral to Treatment for Adolescent Substance Use in Primary Care: Protocol for a Multisite Randomized Effectiveness Trial

Hogue A, Porter NP, Ozechowski TJ, Becker SJ, O'Grady MA, Bobek M, Cerniglia M, Ambrose K, MacLean A, Hadland SE, Cunningham H, Bagley SM, Sherritt L, O'Connell M, Shrier LA, Harris SK

Standard Versus Family-Based Screening, Brief Intervention, and Referral to Treatment for Adolescent Substance Use in Primary Care: Protocol for a Multisite Randomized Effectiveness Trial

JMIR Res Protoc 2024;13:e54486

DOI: 10.2196/54486

PMID: 38819923

PMCID: 11179044

Standard versus Family-based Screening, Brief Intervention, and Referral to Treatment for Adolescent Substance Use in Primary Care: Study Protocol for a Multisite Randomized Effectiveness Trial

  • Aaron Hogue; 
  • Nicole P Porter; 
  • Timothy J Ozechowski; 
  • Sara J Becker; 
  • Megan A O'Grady; 
  • Molly Bobek; 
  • Monica Cerniglia; 
  • Kevin Ambrose; 
  • Alexandra MacLean; 
  • Scott E Hadland; 
  • Hetty Cunningham; 
  • Sarah M Bagley; 
  • Lon Sherritt; 
  • Maddie O'Connell; 
  • Lydia A Shrier; 
  • Sion Kim Harris

ABSTRACT

Background:

Screening, brief intervention, and referral to treatment for adolescents (SBIRT-A) is widely recommended to promote detection and early intervention for alcohol and other drug (AOD) use in pediatric primary care. Existing SBIRT-A procedures rely almost exclusively on adolescents alone, despite recognition of caregivers as critical protective factors in adolescent development and AOD use. Moreover, controlled SBIRT-A studies conducted in primary care have yielded inconsistent findings about implementation feasibility and effects on AOD outcomes and overall developmental functioning. There is urgent need to investigate the value of systematically incorporating caregivers in SBIRT-A procedures.

Objective:

This randomized effectiveness trial compares a standard adolescent-only approach (SBIRT-A-Standard) versus a family-based approach (SBIRT-A-Family) in which caregivers are systematically included in SBIRT-A activities.

Methods:

The study includes N = 2,300 adolescents (age 12 – 17) and their caregivers attending one of three hospital-affiliated pediatric settings serving diverse patient populations in major urban areas. Study recruitment, screening, randomization, and all SBIRT-A activities occur during a single pediatric visit. SBIRT-A procedures are delivered digitally on hand-held tablets using patient-facing and provider-facing programming. Primary outcomes (AOD use, co-occurring behavior problems, parent-youth communication about AOD use) and secondary outcomes (adolescent quality of life, therapy attendance) are assessed at screen/initial and 3, 6, 9, and 12 months follow-up. The study is well powered to conduct all planned main and moderator (age, sex, race/ethnicity, youth AOD risk status) analyses.

Results:

Study recruitment is expected to begin in February 2024.

Conclusions:

Trial results will inform the critical health decision of whether and how to include caregivers in SBIRT-A activities conducted in pediatric primary care. Clinical Trial: ClinicalTrials.gov NCT05964010; Registered 7 July 2023


 Citation

Please cite as:

Hogue A, Porter NP, Ozechowski TJ, Becker SJ, O'Grady MA, Bobek M, Cerniglia M, Ambrose K, MacLean A, Hadland SE, Cunningham H, Bagley SM, Sherritt L, O'Connell M, Shrier LA, Harris SK

Standard Versus Family-Based Screening, Brief Intervention, and Referral to Treatment for Adolescent Substance Use in Primary Care: Protocol for a Multisite Randomized Effectiveness Trial

JMIR Res Protoc 2024;13:e54486

DOI: 10.2196/54486

PMID: 38819923

PMCID: 11179044

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.